Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00NRB
|
||||
Former ID |
DNC006050
|
||||
Drug Name |
MCL-117
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527951] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H23NO
|
||||
Canonical SMILES |
C#CCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
|
||||
InChI |
1S/C19H23NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h1,6-7,13,16,18,21H,3-5,8-12H2/t16-,18+,19+/m0/s1
|
||||
InChIKey |
OKICQDFBWUMTDE-QXAKKESOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [527951] | |
Delta-type opioid receptor | Target Info | Inhibitor | [527951] | ||
Kappa-type opioid receptor | Target Info | Inhibitor | [527951] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.